Policy / Pricing Makary resigns, with Diamantas named as acting FDA commissioner Pharmaceutical TechnologyThe resignation comes after reports suggested the President was considering firing him.Read full story pharminent May 12, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology The resignation comes after reports suggested the President was considering firing him. Read full story Post navigation Previous: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugNext: Isomorphic Labs receives $2.1bn for AI drug development Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026